AI assistant
bioAffinity Technologies, Inc. — Director's Dealing 2024
Jan 25, 2024
35439_dirs_2024-01-24_5c00bf97-6045-4fb1-a0fe-2012defc29b3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2023-10-01
Reporting Person: DIAMOND STUART (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-10-01 | Common Stock | A | 11867 | $1.58 | Acquired | 44340 | Direct |
| 2024-01-01 | Common Stock | A | 12668 | $1.48 | Acquired | 57008 | Direct |
Footnotes
F1: Represents a grant from the Issuer to Mr. Diamond of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
F2: Represents a grant from the Issuer to Mr. Diamond of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which
represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year